Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Q3 2015 · 10-Q
Revenue$4.46M$4.46Mno prior Q3 2014 on file Net Income-$159.55K-$159.55KN/M vs Q3 2014 EPS Diluted-$0.02-$0.02— vs Q3 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,478,272N/M Margins · derivedGross margin32.3%
Operating margin-7.1%
Net margin-3.6%
ended Sep 30, 2015 · filed Nov 23, 2015 · 54 d after period end